Literature DB >> 24816552

Complement deficiencies in systemic lupus erythematosus.

Angela R Bryan1, Eveline Y Wu.   

Abstract

The complement system is a major, multifunctional part of innate immunity and serves as a bridge between the innate and adaptive immune systems. It consists of more than 30 distinct proteins that interact with one another in a specific sequence. There are three pathways of complement activation: the classical, the lectin, and the alternative pathways. The three pathways are initiated by distinct mechanisms, but they all generate the same core set of effector molecules. Inherited complete deficiencies in complement components are generally very rare and predispose to infections and autoimmune disease. One of the better described associations is between deficiencies in early classical pathway components and the development of systemic lupus erythematosus. The goal of this review will be to discuss the associations between and the causal mechanisms of complement deficiencies and systemic lupus erythematosus.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24816552     DOI: 10.1007/s11882-014-0448-2

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  34 in total

Review 1.  The role of the complement system in innate immunity.

Authors:  Horea Rus; Cornelia Cudrici; Florin Niculescu
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 2.  Complement deficiencies in humans and animals: links to autoimmunity.

Authors:  M J Lewis; M Botto
Journal:  Autoimmunity       Date:  2006-08       Impact factor: 2.815

Review 3.  The complement system in systemic autoimmune disease.

Authors:  Min Chen; Mohamed R Daha; Cees G M Kallenberg
Journal:  J Autoimmun       Date:  2009-12-11       Impact factor: 7.094

4.  Reciprocal changes in complement activity and immune-complex levels during plasma infusion in a C2-deficient SLE patient.

Authors:  K Erlendsson; K Traustadóttir; J Freysdóttir; K Steinsson; I Jónsdóttir; H Valdimarsson
Journal:  Lupus       Date:  1993-06       Impact factor: 2.911

5.  Clinical variability and characteristic autoantibody profile in primary C1q complement deficiency.

Authors:  G Vassallo; R W Newton; S E Chieng; M R Haeney; A Shabani; P D Arkwright
Journal:  Rheumatology (Oxford)       Date:  2007-10       Impact factor: 7.580

6.  C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis.

Authors:  Christian Lood; Birgitta Gullstrand; Lennart Truedsson; Anders I Olin; Gunnar V Alm; Lars Rönnblom; Gunnar Sturfelt; Maija-Leena Eloranta; Anders A Bengtsson
Journal:  Arthritis Rheum       Date:  2009-10

Review 7.  The role of complement in the development of systemic lupus erythematosus.

Authors:  Anthony P Manderson; Marina Botto; Mark J Walport
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

8.  Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cells.

Authors:  B Gullstrand; U Mårtensson; G Sturfelt; A A Bengtsson; L Truedsson
Journal:  Clin Exp Immunol       Date:  2009-03-02       Impact factor: 4.330

9.  Genetically determined partial complement C4 deficiency states are not independent risk factors for SLE in UK and Spanish populations.

Authors:  Lora Boteva; David L Morris; Josefina Cortés-Hernández; Javier Martin; Timothy J Vyse; Michelle M A Fernando
Journal:  Am J Hum Genet       Date:  2012-03-01       Impact factor: 11.025

10.  Recombinant human complement component C2 produced in a human cell line restores the classical complement pathway activity in-vitro: an alternative treatment for C2 deficiency diseases.

Authors:  Paolo G V Martini; Lynette C Cook; Scott Alderucci; Angela W Norton; Dianna M Lundberg; Susan M Fish; Knut Langsetmo; Göran Jönsson; Christian Lood; Birgitta Gullstrand; Kate J Zaleski; Nancy Savioli; Jason Lottherand; Charles Bedard; John Gill; Michael F Concino; Michael W Heartlein; Lennart Truedsson; Jan L Powell; Arthur O Tzianabos
Journal:  BMC Immunol       Date:  2010-08-20       Impact factor: 3.615

View more
  15 in total

1.  Collectin liver 1 and collectin kidney 1 and other complement-associated pattern recognition molecules in systemic lupus erythematosus.

Authors:  A Troldborg; S Thiel; L Jensen; S Hansen; M J Laska; B Deleuran; J C Jensenius; K Stengaard-Pedersen
Journal:  Clin Exp Immunol       Date:  2015-08-31       Impact factor: 4.330

Review 2.  Production of complement components by cells of the immune system.

Authors:  R Lubbers; M F van Essen; C van Kooten; L A Trouw
Journal:  Clin Exp Immunol       Date:  2017-03-24       Impact factor: 4.330

Review 3.  Systemic lupus erythematosus biomarkers: the challenging quest.

Authors:  Cristina Arriens; Jonathan D Wren; Melissa E Munroe; Chandra Mohan
Journal:  Rheumatology (Oxford)       Date:  2017-04-01       Impact factor: 7.580

Review 4.  Monogenic Lupus.

Authors:  Mindy S Lo
Journal:  Curr Rheumatol Rep       Date:  2016-12       Impact factor: 4.592

Review 5.  Common dermatologic manifestations of primary immune deficiencies.

Authors:  Manisha Relan; Heather K Lehman
Journal:  Curr Allergy Asthma Rep       Date:  2014-12       Impact factor: 4.919

6.  SLE and Serum Complement: Causative, Concomitant or Coincidental?

Authors:  Vaneet Sandhu; Michele Quan
Journal:  Open Rheumatol J       Date:  2017-09-30

Review 7.  Approach to a Child with Primary Immunodeficiency Made Simple.

Authors:  Dhrubajyoti Sharma; Ankur K Jindal; Amit Rawat; Surjit Singh
Journal:  Indian Dermatol Online J       Date:  2017 Nov-Dec

Review 8.  Revisiting B cell tolerance and autoantibodies in seropositive and seronegative autoimmune rheumatic disease (AIRD).

Authors:  J N Pouw; E F A Leijten; J M van Laar; M Boes
Journal:  Clin Exp Immunol       Date:  2020-11-15       Impact factor: 4.330

9.  Complement C4 induces regulatory T cells differentiation through dendritic cell in systemic lupus erythematosus.

Authors:  Hong-Bin Cheng; Rong-Yi Chen; Jing-Ping Wu; Li Chen; Yan-Hua Liang; Hai-Feng Pan; Zi-Feng Pan; Qing-Hua Zhang; Qing Li; Tian-Xi Du; Yong-Mei Lv; Jian-Qiang Shi
Journal:  Cell Biosci       Date:  2015-12-23       Impact factor: 7.133

10.  The HLA-B*35 allele modulates ER stress, inflammation and proliferation in PBMCs from Limited Cutaneous Systemic Sclerosis patients.

Authors:  Stefania Lenna; Shervin Assassi; G Alessandra Farina; Julio C Mantero; Raffaella Scorza; Robert Lafyatis; Harrison W Farber; Maria Trojanowska
Journal:  Arthritis Res Ther       Date:  2015-12-16       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.